{{Rsnum
|rsid=1557351
|Chromosome=18
|position=57085083
|Orientation=plus
|GMAF=0.3118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 30.1 | 68.1
| HCB | 19.0 | 43.8 | 37.2
| JPT | 12.4 | 44.2 | 43.4
| YRI | 8.2 | 33.3 | 58.5
| ASW | 14.0 | 40.4 | 45.6
| CHB | 19.0 | 43.8 | 37.2
| CHD | 18.3 | 51.4 | 30.3
| GIH | 3.0 | 26.7 | 70.3
| LWK | 16.4 | 48.2 | 35.5
| MEX | 17.2 | 48.3 | 34.5
| MKK | 9.6 | 42.3 | 48.1
| TSI | 6.9 | 35.3 | 57.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (age of onset)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs1557351
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 978 cases, 883 controls; Replication Sample Size: NR); (Region: 18q21.31; Reported Gene(s): WDR7; Risk Allele: rs1557351-?); (p-value= 0.000004).This variant is associated with Multiple sclerosis (age of onset).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740718
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1557351
|overall_frequency_n=38
|overall_frequency_d=128
|overall_frequency=0.296875
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}